Chae YS - Search Results

1

A pH-responsive carboxymethyl dextran-based conjugate as a carrier of docetaxel for cancer therapy.

Han HS, Lee M, An JY, Son S, Ko H, Lee H, Chae YS, Kang YM, Park JH. Han HS, et al. Among authors: chae ys. J Biomed Mater Res B Appl Biomater. 2016 May;104(4):789-96. doi: 10.1002/jbm.b.33581. Epub 2015 Dec 21. J Biomed Mater Res B Appl Biomater. 2016. PMID: 26687579

2

Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.

Han HS, Thambi T, Choi KY, Son S, Ko H, Lee MC, Jo DG, Chae YS, Kang YM, Lee JY, Park JH. Han HS, et al. Among authors: chae ys. Biomacromolecules. 2015 Feb 9;16(2):447-56. doi: 10.1021/bm5017755. Epub 2015 Jan 7. Biomacromolecules. 2015. PMID: 25565417

3

Gold-installed biostable nanocomplexes for tumor-targeted siRNA delivery in vivo.

Heo R, Yoon HY, Ko H, Shin JM, Jeon J, Chae YS, Kang YM, Kim D, Lee DS, Park JH. Heo R, et al. Among authors: chae ys. Chem Commun (Camb). 2015 Dec 4;51(93):16656-9. doi: 10.1039/c5cc05639j. Epub 2015 Oct 1. Chem Commun (Camb). 2015. PMID: 26426483

4

Tumor microenvironment-specific nanoparticles activatable by stepwise transformation.

Ko H, Son S, Jeon J, Thambi T, Kwon S, Chae YS, Kang YM, Park JH. Ko H, et al. Among authors: chae ys. J Control Release. 2016 Jul 28;234:68-78. doi: 10.1016/j.jconrel.2016.05.009. Epub 2016 May 6. J Control Release. 2016. PMID: 27164544

5

AQP5 Variants Affect Tumoral Expression of AQP5 and Survival in Patients with Early Breast Cancer.

Lee SJ, Kang BW, Kim JG, Jung JH, Lee J, Kim WW, Park HY, Jeong JH, Jeong JY, Park JY, Park JH, Chae YS. Lee SJ, et al. Among authors: chae ys. Oncology. 2017;92(3):153-160. doi: 10.1159/000452715. Epub 2016 Dec 16. Oncology. 2017. PMID: 27978515

6

Overcoming Tamoxifen Resistance by Regulation of Del-1 in Breast Cancer.

Lee J, Jeong JH, Jung JH, Kim WW, Lee SJ, Park JY, Park JY, Kang SH, Kim EA, Park JH, Chae YS, Park HY. Lee J, et al. Among authors: chae ys. Oncology. 2019;97(3):180-188. doi: 10.1159/000501340. Epub 2019 Jul 22. Oncology. 2019. PMID: 31330520

7

Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.

Kim JG, Sohn SK, Chae YS, Song HS, Kwon KY, Do YR, Kim MK, Lee KH, Hyun MS, Ryoo HM, Bae SH, Park KU, Lee WS, Baek JH, Chung HY, Yu W. Kim JG, et al. Among authors: chae ys. Br J Cancer. 2008 Feb 12;98(3):542-6. doi: 10.1038/sj.bjc.6604188. Epub 2008 Jan 22. Br J Cancer. 2008. PMID: 18212754 Free PMC article. Clinical Trial.

8

Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer.

Kim JY, Ryoo HM, Bae SH, Kang BW, Chae YS, Yoon S, Baek JH, Kim MK, Lee KH, Lee SA, Song HS, Kim JG. Kim JY, et al. Among authors: chae ys. Anticancer Res. 2015 Jun;35(6):3531-6. Anticancer Res. 2015. PMID: 26026121 Clinical Trial.

9

Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells.

Lee SJ, Jeong JH, Lee IH, Lee J, Jung JH, Park HY, Lee DH, Chae YS. Lee SJ, et al. Among authors: chae ys. Anticancer Res. 2019 Feb;39(2):751-758. doi: 10.21873/anticanres.13172. Anticancer Res. 2019. PMID: 30711954

10

Anticancer effect of (E)-2-hydroxy-3',4,5'-trimethoxystilbene on breast cancer cells by mitochondrial depolarization.

Chae YS, Kim JG, Jung HJ, Yang JD, Jung JH, Aiyar SE, Kim S, Park H. Chae YS, et al. Cancer Chemother Pharmacol. 2011 Aug;68(2):349-58. doi: 10.1007/s00280-010-1464-0. Epub 2010 Oct 27. Cancer Chemother Pharmacol. 2011. PMID: 20978764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters